-
Kangfang Bio-IL-4R monoclonal antibody was approved for clinical indication for moderate to severe atopic dermatitis
Time of Update: 2021-04-18
On April 8, the CDE official website showed that Kangfang Biologics Class 1 new drug AK120 injection was approved for clinical use, and the indication is moderate to severe atopic dermatitis.
AK120 is a new type of autoimmune disease treatment drug that targets IL-4R independently developed by Kangfang Biology.
-
Cansino: 13-valent pneumococcal polysaccharide conjugate vaccine enters phase III clinical trial
Time of Update: 2021-04-18
In developed countries and regions, the introduction and widespread use of pneumococcal polysaccharide conjugate vaccines have effectively controlled serious diseases caused by Streptococcus pneumoniae.
The introduction of pneumococcal polysaccharide conjugate vaccine is the main means to achieve this goal.
-
19 pharmaceutical companies were issued fines, but these "cats and tricks" were discovered!
Time of Update: 2021-04-18
19 pharmaceutical companies is the Ministry of Finance punished included the head of the market value of one hundred billion of domestic enterprises According to an announcement issued by the Ministry of Finance on the 12th, in 2019, the Ministry of Finance, in conjunction with the National Medical Insurance Administration, will conduct accounting information quality inspections on 77 pharmaceutical companies.
-
Individual vaccinators do not need to be overly anxious for psychogenic reactions
Time of Update: 2021-04-17
Why is it that in the process of vaccinating the new crown vaccine this time, it cannot be vaccinated with other vaccines, including HPV vaccine, under normal circumstances, Wang Huaqing said, mainly considering the identification of adverse reactions.
-
The new crown vaccination rate for population protection needs to be 70%, 80%
Time of Update: 2021-04-17
Wu Zunyou, chief epidemiologist of the Chinese Center for Disease Control and Prevention, pointed out that the new crown vaccine needs to be vaccinated to 70% and 80% of the population in order to produce a group protection effect.
-
Some units have a one-size-fits-all vaccination phenomenon, the National Health Commission responded
Time of Update: 2021-04-17
The National Health Commission responded BEIJING, April 11 power of the State Council joint prevention and control mechanism to hold a press conference on the 11th afternoon, Wei Jian, deputy director of the National Committee of Disease Control Bureau Wu Liang had said at the meeting, in some areas the process of promoting new crown virus vaccination efforts in the , There are simplification problems.
-
Expert: The vast majority of people such as rhinitis and pharyngitis can be vaccinated against the new crown vaccine
Time of Update: 2021-04-17
Regarding allergies, Wang Huaqing pointed out that if the vaccinators are confirmed to have acute allergic symptoms due to the new crown vaccine after the investigation and diagnosis expert group, the vaccinators cannot receive the second shot.
-
Health Commission: 12 new local cases confirmed on the 13th
Time of Update: 2021-04-17
As of 24:00 on April 13, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 298 confirmed cases (including 6 severe cases), 85,513 cured and discharged cases, and 4,636 deaths.
-
The medical insurance bureau's "blacklist" first issued heavy penalties for commercial bribery: the main products of well-known pharmaceutical companies have been suspended from the Internet!
Time of Update: 2021-04-17
Medical Network, April 14 hearing on April 12, Zhejiang Pharmaceutical Equipment Procurement Center issued a notice stating that according to the criminal judgment of the People’s Court of Ouhai Dist
-
List of key special video review experts for digital diagnosis and treatment equipment research and development
Time of Update: 2021-04-17
pdf" target="_blank">List of experts for the video defense review of the key special project of "Active Health and Aging Technology Response" in 2021.
pdf" target="_blank">List of experts for the video defense review of the key special project of "Active Health and Aging Technology Response" in 2021.
-
10 new confirmed cases on April 10, all imported from abroad
Time of Update: 2021-04-17
As of 24:00 on April 10, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 286 confirmed cases (including 4 severe cases), a total of 85,488 cured and discharged cases, and a total of 4,636 deaths.
-
Artificial intelligence cracks the language of cancer and Alzheimer's disease
Time of Update: 2021-04-17
Image source: Weitz lab, Harvard University Recently, scientists have discovered that powerful algorithms used by Netflix, Amazon and Facebook can "predict" the biological language of neurodegenerative diseases such as cancer and Alzheimer's disease.
-
Gao Fu: Don't ignore the infinite possibilities of mRNA vaccines
Time of Update: 2021-04-17
" On April 10, Gao Fu, director of the Chinese Center for Disease Control and Prevention, appealed at the 2021 National Vaccine and Health Conference that mRNA technology is effective for infectious diseases, AIDS , and genetic diseases.
-
16 new cases were confirmed on April 11, and 2 local cases were in Yunnan
Time of Update: 2021-04-17
As of 24:00 on April 11, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 295 confirmed cases (including 3 severe cases), a total of 85,495 cured and discharged cases, and a total of 4,636 deaths.
-
Study: AstraZeneca vaccine can cause extremely high levels of antibodies to cause blood clots
Time of Update: 2021-04-17
On April 10th, local time, the Norwegian Radio and Television Company (NRK) reported that the Norwegian study pointed out that there is a link between the AstraZeneca vaccine and blood clots, but researchers still do not know which substances in the vaccine can trigger this side effect.
-
Cervical cancer market: Bio-similar drugs are on the rise, and vaccines differ significantly in domestic and foreign patterns
Time of Update: 2021-04-17
The Chinese market has recovered in the second half of 2020 On July 12, 2016, the State Food and Drug Administration approved GlaxoSmithKline’s application for import registration of a recombinant bivalent vaccine for cervical cancer that is a preventive biological product.
-
U.S. disease control recommends suspending the use of Johnson & Johnson vaccine after multiple vaccination with blood clots
Time of Update: 2021-04-17
S. Disease Control recommends suspending the use of Johnson & Johnson vaccine, if multiple people experience thrombosis after vaccination, U.
S. Disease Control recommends suspending the use of Johnson & Johnson vaccine, if multiple people experience thrombosis after vaccination China News Service, April 13th.
-
She used it as a "medicine" to fight against inflammation
Time of Update: 2021-04-17
Academy of Sciences Today’s Cui Jinjiang, on the one hand, wants to find the excitement of doctors, leads the scientific research team to brainstorm with doctors, develops medical devices suitable for China’s national conditions, and relieves patients’ pain; on the other hand, he has to look for market opportunities and consider how to make domestically produced products that meet China’s national conditions Medical equipment enters hospitals and thousands of households.
-
Don't be stopped by these rumors
Time of Update: 2021-04-17
State Council Feng Zijian said that there are two issues that need to be considered: on the one hand, the current global epidemic has not completely subsided; on the other hand, my country's vaccination rate is still low, and there is still a long way to go from a high level of population immunity.
-
The mutated new coronavirus reported in the UK will not aggravate the condition of hospitalized patients
Time of Update: 2021-04-17
A team led by researchers from University College London analyzed the condition of 496 new crown patients admitted to two British hospitals between November 9 and December 20 last year, and selected 341 samples of them.
